Details of the Drug Reposition

General Information of This Drug (ID: DM12UX6)

Drug Name
131 I-omburtamab   DM12UX6
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2/3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Brain and central nervous system tumour DISMJOSR 2A00.11 Phase 2/3 [1]
Neuroblastoma DISVZBI4 2D11.2 Phase 2/3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03275402) 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases. U.S. National Institutes of Health.